Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies. Thromb Res 1996 Dec 01;84(5):361-5
Date
12/01/1996Pubmed ID
8948063DOI
10.1016/s0049-3848(96)00200-9Scopus ID
2-s2.0-0030561510 (requires institutional sign-in at Scopus site) 34 CitationsAuthor List
Simantov R, Lo SK, Salmon JE, Sammaritano LR, Silverstein RLAuthor
Roy L. Silverstein MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antibodies, AntiphospholipidBiomarkers
Factor V
Heterozygote
Humans
Lupus Erythematosus, Systemic
Thrombosis
